Benzyl alcohol 0.1 ML/ML / pramoxine hydrochloride 0.01 MG/MG Topical Gel — RxCUI 1293632
RxNorm drug concept · Semantic clinical drug
RxCUI 1293632
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1293632
Official nameBenzyl alcohol 0.1 ML/ML / pramoxine hydrochloride 0.01 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asbenzyl alcohol 10 % / pramoxine hydrochloride 1 % Topical Gel; pramoxine HCl 1 % / benzyl alcohol 10 % Topical Gel
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Benzyl Alcohol Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It temporarily relieves pain from cold sores, fever blisters, canker sores, mouth sores and gum irritation. It eases the pain while the sore is there.
- Dry the sore first. Then dab it on with a cotton swab or clean finger. You can use it up to 4 times a day, and it should dry in about 30 to 60 seconds.
- Children 2 and older can use it, and children under 12 should have an adult supervise. Do not use it in children under 2 unless a physician or dentist says so.
- Do not use it for more than 7 days unless a physician or dentist directs you to. If the sore has not improved by then, it is time to get it checked.
🕸️ Concept Web — How Benzyl alcohol 0.1 ML/ML / pramoxine hydrochlori... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Benzyl alcohol 0.1 ML/ML / pramoxine hydrochloride 0.01 MG/MG Topical Gel
RxCUI 1293632 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Benzyl alcohol
1426IN -
Pramoxine
34347IN -
Benzyl alcohol / pramoxine
1007900MIN -
Pramoxine hydrochloride
57555PIN
-
Benzyl alcohol
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Itch-X
217826BN
-
Itch-X
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Benzyl alcohol / pramoxine Topical Gel
378016SCDF -
Benzyl alcohol / pramoxine hydrochloride Topical Gel
2645826SCDFP -
Benzyl alcohol / pramoxine Topical Product
1153262SCDG -
Benzyl alcohol / pramoxine hydrochloride Topical Product
2663090SCDGP -
Benzyl alcohol / pramoxine Topical Gel [Itch-X]
1101861SBDF -
Benzyl alcohol / pramoxine hydrochloride Topical Gel [Itch-X]
2656611SBDFP -
Itch-X Topical Product
1167180SBDG -
Topical Gel
346286DF - +1 more in this family
-
Benzyl alcohol / pramoxine Topical Gel
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Benzyl alcohol 0.1 ML/ML
581454SCDC -
Pramoxine hydrochloride 0.01 MG/MG
995190SCDC -
Benzyl alcohol 0.1 ML/ML / pramoxine hydrochloride 0.01 MG/MG Topical Gel [Itch-X]
1293634SBD -
Benzyl alcohol 0.1 ML/ML / pramoxine hydrochloride 0.01 MG/MG [Itch-X]
1293633SBDC
-
Benzyl alcohol 0.1 ML/ML
Showing up to 8 concepts per family — 17 of 18 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Benzyl alcohol 0.1 ML/ML
SCDC · 581454 -
Pramoxine hydrochloride 0.01 MG/MG
SCDC · 995190 -
Benzyl alcohol / pramoxine Topical Gel
SCDF · 378016 -
Benzyl alcohol / pramoxine hydrochloride Topical Gel
SCDFP · 2645826 -
Benzyl alcohol / pramoxine Topical Product
SCDG · 1153262 -
Benzyl alcohol / pramoxine hydrochloride Topical Product
SCDGP · 2663090
Brand-Name Concepts
-
Benzyl alcohol 0.1 ML/ML / pramoxine hydrochloride 0.01 MG/MG Topical Gel [Itch-X]
SBD · 1293634 -
Benzyl alcohol 0.1 ML/ML / pramoxine hydrochloride 0.01 MG/MG [Itch-X]
SBDC · 1293633 -
Benzyl alcohol / pramoxine Topical Gel [Itch-X]
SBDF · 1101861 -
Benzyl alcohol / pramoxine hydrochloride Topical Gel [Itch-X]
SBDFP · 2656611 -
Itch-X Topical Product
SBDG · 1167180 -
Itch-X
BN · 217826
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1293632 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00225-0495-33 | 35.4 g in 1 TUBE (0225-0495-33) | ITCH X | BF ASCHER AND CO INC | 2014-09-19 |
Observed labelers:
BF ASCHER AND CO INC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.